Eli Lilly extends partnership with Insilico Medicine for AI drug discovery
Pharmaceutical company Eli Lilly has expanded its existing partnership with AI company Insilico Medicine to use artificial intelligence for drug discovery efforts. The deal extends their previous collaboration focused on applying AI technology to pharmaceutical research and development.
8
Divergence score
2 outlets covered it, splitting into 2 framing camps across 2 bias groups.
2 camps
2 bias groups
The spectrum · how 2 outlets placed this story
LeftCenterRight
Wall Street Journal
Reuters
Supportive of action
Neutral
Dismissive
Critical
Alarmist
International angle
How each outlet covered it
Lightly covered so far
Too few outlets to map a left-right split. Here is each take as it stands.
Sparse coverage · 2 outlets
“Eli Lilly extends partnership with Insilico Medicine for AI-powered drug discovery - Reuters”
“Eli Lilly, InSilico Strike AI Drug Discovery Deal - WSJ”
Tracked claims from across the political spectrum
Fact ledger
Corroborated
Disputed